维普中文期刊产品整合服务
12篇 您的检索式:作者名="Misselwitz F"
    题名 作者 年代 出处 被引量
1Incidence and clinical relevance of heparin induced antibodies in patients with deep vein thrombosis treated with unfractionated or low- molecular weight heparin 显示文摘Lindhoff- Last E Nakov R Misselwitz F 2002Br J Haematol2002,118,4:1
2Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial显示文摘Ajay K Kakkar Benjamin Brenner Ola E Dahl Bengt I Eriksson Patrick Mouret Jim Muntz Andrea G Soglian ákos F Pap Frank Misselwitz Sylvia Haas 2008The Lancet2008,,9632:1
3The discovery and development of rivaroxaban显示文摘MISSELWITZ F BERKOWITZ SD PERZBORN E 2011Ann N Y Acad Sci2011,1222,:1
4Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity 显示文摘Graft J von-Hentig N Misselwitz F 2007J Clin Pharmacol2007,47,11:1
5Low-Molecular-weight heparin (reviparin) dimishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy 显示文摘Pross M Lippert H Misselwitz F et el 2003Thromb Res2003,110,:1
6Effects of the oral, di- rect factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activityl 显示文摘Graff J Hentig N Misselwitz F 2007The J Clini Phar- macol2007,47,11:1
7Incidence and clinical relevance of heparin - induced antibodies in patients with deep vein thrombosis treated with unfmctionated or low - molecular -weight hcparin 显示文摘Lindhoff - Last E Nakov R Misselwitz F 2002Br J Haematol2002,118,4:1
8Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin显示文摘Lindhoff Last E Nakov R Misselwitz F 2002Br J Haematol2002,118,4:1
9Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial显示文摘Ajay K Kakkar Benjamin Brenner Ola E Dahl Bengt I Eriksson Patrick Mouret Jim Muntz Andrea G Soglian ákos F Pap Frank Misselwitz Sylvia Haas 2008The Lancet2008,,9632:1
10Prevention of venous thromboembolism after knee arthroscopy with low molecularweight heparin ( revipa- tin): results of a randomized eontrelledtrlal 显示文摘WIRTH T SCHNEIDER B MISSELWITZ F 2001Arthroscopy2001,17,4:1
11Oral rivarexaban for symptomatic venous thromboembolism 显示文摘Bauersacchs R Berkowitz SD Brenner B Bullet HR Decousus H Gallus AS Lensin$ AW Misselwitz F Prins MH Raskob GE Sege A Verhamme P Wells P Agnelli G Bounameaux H Cohen A Da- vidson BL Piove|la F Schellong S 2010N Engl J Med2010,363,26:1
12Effects of the Oral, Direct Factor Xa Inhibitor Rivaroxaban on Platelet-Induced Throm- bin Generation and Prothrombinase Activity 显示文摘Graft J von Hentig N Misselwitz F 2007J Clin Pharma- col2007,47,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费